ArticleAdvanced pharmaceutical bulletin2025

Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway.

Samaneh Siapoush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.